Show results for

Refine by

Locations

Clinical Care Product Applications In Australasia

15 applications found

In Australasia Available In Australasia Near Australasia

Myriad Matrix - Engineered Extracellular Matrix for Hidradenitis SuppurativaClinical Resource

26-Year-old female. Five years of Hurley grade III Hidradenitis Suppurativawith multiple draining and interconnected sinuses. Previously managed with topical antibiotics and laser treatments. Full thickness excision of affected area (~20 x 10 x 4 cm). Myriad Matrix (5-layer, 10 x 20) placed in the defect prior to fasciocutaneous flap mobilization. Cover dressing lost at week 3 leading to minor dehiscence at the incision. Endoform Natural used from week 4 to epithelize the dehisced primary ...

ByAroa Biosurgery Limited based in Mangere, NEW ZEALAND

3D bioprinting technology for stem (developmental) disease

Our RASTRUM matrices support a range of stem cell types and allow for their growth and ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

3D bioprinting technology for breast disease

Our RASTRUM matrices support a range of breast tissue cell types ranging from diseased to healthy cells (MCF-7, BT-474, MDA-MB-231, Breast Fibroblasts, ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

3D bioprinting technology for brain disease

Our RASTRUM matrices support a range of neural tissue cell types ranging from diseased to healthy cells (Glioblastoma, Neuroblastoma, Neurons, Astrocytes, Microglia, ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

3D bioprinting technology for liver disease

Our RASTRUM matrices support a range of liver tissue cell types ranging from diseased to healthy cells (Hepatoma, Stellate Cells, Hepatocytes, ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

Endoform - Antimicrobial and Natural Restorative Bioscaffold for Negative Pressure Wound Therapy

Prospective case controlled study of chronic diabetic foot ulcerations. N=10 DFU - Endoform plus NPWT vs N=10 DFU -NPWT alone. Addition of Endoform® in combination with NPWT reduced time to closure by 18% (1.3 ...

ByAroa Biosurgery Limited based in Mangere, NEW ZEALAND

3D bioprinting technology for lung disease

Our RASTRUM matrices support a range of lung tissue cell types ranging from diseased to healthy cells (A549, Lung Fibroblasts, ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

3D bioprinting technology for prostate disease

Our RASTRUM matrices support a range of prostate tissue cell types ranging from diseased to healthy cells (prostate adenocarcinoma, ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

3D bioprinting technology for ovaries disease

Our RASTRUM matrices support a range of prostate tissue cell types ranging from diseased to healthy cells (ovarian carcinoma ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

3D bioprinting technology for skin disease

Our RASTRUM matrices support a range of skin tissue cell types ranging from diseased to healthy cells (dermal fibroblasts, ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

3D bioprinting technology for pancreas disease

Our RASTRUM matrices support a range of pancreatic tissue cell types ranging from diseased to healthy cells (pancreatic carcinoma, pancreatic adenocarcinoma, ...

ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA

Ocular Implants Technology for Postoperative Bacterial Endophthalmitis

Postoperative bacterial endophthalmitis is a rare but devastating complication that can occur following ocular surgery.1 Without proper intervention, endophthalmitis can cause irreversible damage to structures within the retina resulting in a loss of vision.2 This inflammatory condition affecting the intraocular cavities is typically caused by a bacterial or fungal infection, with the most common causative agents including coagulase-negative staphylococci, Staphylococcus aureus, streptococci and other ...

ByPolyActiva Pty Ltd. based in Parkville, AUSTRALIA

Ocular Implants Technology for Ocular Hypertension and Glaucoma

Ocular Hypertension is defined as elevated intraocular pressure (IOP) without ocular damage and is associated with an increased risk of progression to Glaucoma.1,2 Nearly 7 million adults over the age of 40 in the US are estimated to suffer from Ocular Hypertension. ...

ByPolyActiva Pty Ltd. based in Parkville, AUSTRALIA

Clinical Application - Guideline for the Management of NovoSorb® BTM

NovoSorb® BTM is convenient to store and prepare for application: Provided in a multilayer packaging, it can be stored at room temperature (≤ 25° C); Cut to wound size, no need for reconstituting or other pre-treatment; It does not contain any biological materials or sensitizing proteins, so does not require tissue ...

ByPolyNovo Limited based in Port Melbourne, AUSTRALIA

EndoBarrier - Endoscopically Delivered Medical Device for Clinical Trials

GI Dynamics has taken all necessary COVID-19 precautions to ensure patient safety, which remains top priority. Patient screening for the STEP-1 pivotal trial of EndoBarrier has reopened at select sites and enrollment will be conducted according to site requirements and CDC/FDA ...

ByGI Dynamics, Inc. based in Boston, MASSACHUSETTS (USA)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you